Vaccine studies with the 32H reisolate of SIVmac251: an overview.
Cranage
M
M
Division of Pathology, PHLS Centre for Applied Microbiology and Research, Porton Down, Salisbury, England.
Stott
J
J
Mills
K
K
Ashworth
T
T
Taffs
F
F
Farrar
G
G
Chan
L
L
Dennis
M
M
Putkonen
P
P
Biberfeld
G
G
D000276:Adjuvants, Immunologic; D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D008252:Macaca fascicularis / Q000276:immunology; D008253:Macaca mulatta / Q000276:immunology; D011994:Recombinant Proteins / Q000276:immunology; D016097:Simian Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D015302:Simian Immunodeficiency Virus / Q000276:immunology*; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000276:immunology; D015164:Vaccines, Inactivated / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology
D000276:Adjuvants, Immunologic; D000956:Antigens, Viral; D011994:Recombinant Proteins; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic; D014765:Viral Vaccines